1. Home
  2. FCBC vs AURA Comparison

FCBC vs AURA Comparison

Compare FCBC & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Bankshares Inc. (VA)

FCBC

First Community Bankshares Inc. (VA)

HOLD

Current Price

$45.12

Market Cap

851.3M

Sector

Finance

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.74

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCBC
AURA
Founded
1874
2007
Country
United States
United States
Employees
610
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
851.3M
713.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
FCBC
AURA
Price
$45.12
$7.74
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.00
AVG Volume (30 Days)
84.1K
661.7K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
5.26%
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
N/A
N/A
Revenue This Year
$12.28
N/A
Revenue Next Year
$2.55
N/A
P/E Ratio
$71.62
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.21
$4.73
52 Week High
$45.84
$9.54

Technical Indicators

Market Signals
Indicator
FCBC
AURA
Relative Strength Index (RSI) 59.45 63.14
Support Level $41.04 $5.18
Resistance Level N/A $7.81
Average True Range (ATR) 1.09 0.50
MACD 0.13 0.12
Stochastic Oscillator 79.78 99.37

Price Performance

Historical Comparison
FCBC
AURA

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: